- Injection prices
- $124 listed; $99 first-order headline with DW20
- Nasal prices
- $139 listed; $111 first-order headline with DW20
- Nasal specification
- 15 mL at 150 mg/mL
- Billing basis
- Confirm supply period and renewal conditions
Two NAD+ offers with different package information
Good Life Meds lists NAD+ injections and NAD+ nasal spray as separate prescription offerings within its daily-wellness range. The injection page describes a 1,000 mg vial, while the nasal page identifies 15 mL at 150 mg/mL. Those details help identify the purchases without implying that their quantities or clinical effects are interchangeable.
The provider describes online care and fulfillment through US pharmacies, with no membership requirement in its broader service presentation. We have not completed an intake or tested the support and delivery process. A no-membership statement is a commercial feature, not proof that every assessment, test or future order is included without another charge.
Preserve the first-order promotion
The injection page shows a $124 list figure and a $99 promotional headline. The nasal page shows $139 and $111 respectively. Both advertise a first-order reduction using the code DW20. Those conditions should remain attached to the lower figures, rather than allowing an introductory number to become the assumed ongoing price.
The displayed promotion uses rounded dollar headlines, so the exact checkout calculation should be confirmed rather than reconstructed from a percentage alone. Also establish the supply and renewal basis. The public product cards do not clearly show that every listed price is a calendar-month subscription or that the first order's terms continue unchanged indefinitely.
Included care and quality claims
The nasal listing expressly includes the bottle, expedited shipping, a consultation and ongoing doctor care. The injection page advertises free expedited shipping, but its exact package and assessment inclusions should still be confirmed. Service descriptions should not be stretched into a promise of immediate clinician responses or guaranteed delivery on a specific day.
Good Life Meds publishes descriptions of quality-testing categories. We did not inspect a batch report for a dispensed NAD+ product or independently audit the laboratory process. Ask for the preparation's pharmacy identity and relevant quality documentation, including the attributes tested and the connection between the report and the batch supplied.
Keep the marketed benefits product-specific
The pages discuss energy, mental clarity and aging-related benefits. Some surrounding testimonials concern other products, which cannot establish outcomes from NAD+. We have not verified a finished-product clinical trial demonstrating the advertised effects for these particular injection and nasal preparations, and ingredient-level biology does not resolve that limitation.
Ask the clinician what supports the intended use, then confirm formulation, storage, follow-up and the full payment schedule. Compounded products are not FDA-approved, even when a pharmacy is licensed or regulated. This provider adds useful route-specific documentation and an explicit first-order promotion to the comparison; its remaining gaps concern the complete billing basis, actual prescription and product-specific evidence.
Useful distinctions
- Separate injection and nasal product pages
- Promotion is explicitly tied to a first order
- Nasal volume and concentration published
Limitations to weigh
- Headline prices do not establish a full renewal schedule
- Promotional arithmetic should be confirmed at checkout
- Testing and clinical outcomes not independently audited
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.